Necroptosis, as a novel programmed form of necrotic cell death different from apoptosis, can enhance CD8+ leukocyte-mediated antitumor immunity by activating RIPK1 and RIPK3 within the tumor microenvironment (TME) [6]. The gene discussed is CD8A; the disease is neoplasm.